Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
XERIS BIOPHARMA HOLDINGS, INC. (XERS), most recent 12 months reported: revenue $368.26M, net loss $6.5M, free cash flow $27.93M. Latest balance sheet on file: liquid cash $111.04M, total debt $220.34M, net cash -$109.29M. From SEC filings. More on XERIS BIOPHARMA HOLDINGS, INC.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: INNOVIVA, INC. · MannKind Corporation · IRONWOOD PHARMACEUTICALS INC · SINOVAC BIOTECH LTD · ORGANOGENESIS HOLDINGS INC. · EVOLUS, INC. · Aurinia Pharmaceuticals Inc. · Syndax Pharmaceuticals, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.